Volume 70, Issue 11, Pages (December 2006)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 6, Pages (December 2004)
Advertisements

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 63, Issue 2, Pages (February 2003)
Plasma sodium and hypertension
Cellular mechanisms of renal osteodystrophy
Volume 69, Issue 6, Pages (March 2006)
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 70, Issue 4, Pages (August 2006)
Volume 60, Issue 3, Pages (September 2001)
Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali.
Volume 67, Issue 2, Pages (February 2005)
Membranous nephropathy: When and how to treat
Volume 68, Issue 5, Pages (November 2005)
Innate immunity as a driving force in renal disease
Volume 67, Issue 4, Pages (April 2005)
Urinary cystine excretion and capacity in patients with cystinuria
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 54, Issue 4, Pages (October 1998)
Volume 71, Issue 8, Pages (April 2007)
Volume 70, Issue 3, Pages (August 2006)
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 77, Issue 7, Pages (April 2010)
Volume 67, Issue 3, Pages (March 2005)
Volume 70, Issue 11, Pages (December 2006)
Volume 71, Issue 11, Pages (June 2007)
Volume 60, Issue 6, Pages (December 2001)
Volume 69, Issue 6, Pages (March 2006)
Volume 69, Issue 10, Pages (May 2006)
Lane J. Brunner, William M. Bennett, Dennis R. Koop 
17-β Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters  S. Riazi, C. Maric, C.A. Ecelbarger 
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 67, Issue 1, Pages (January 2005)
Volume 57, Issue 5, Pages (May 2000)
Volume 70, Issue 10, Pages (November 2006)
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 2, Pages (February 2003)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Fructose intake as a risk factor for kidney stone disease
Volume 70, Issue 10, Pages (November 2006)
Volume 72, Issue 8, Pages (October 2007)
Volume 71, Issue 9, Pages (May 2007)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 66, Issue 6, Pages (December 2004)
Volume 73, Issue 3, Pages (February 2008)
Volume 69, Issue 4, Pages (February 2006)
Mineralocorticoid selectivity: Molecular and cellular aspects
Endothelin antagonists in renal disease
Volume 60, Issue 5, Pages (November 2001)
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
Volume 56, Issue 6, Pages (December 1999)
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Urinalysis in Western culture: A brief history
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.
Volume 71, Issue 9, Pages (May 2007)
Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease  A.R. Chade, D. Brosh, S.T.
Volume 62, Issue 5, (November 2002)
T cells and T-cell receptors in acute renal failure
Volume 61, Issue 1, Pages (January 2002)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 69, Issue 11, Pages (June 2006)
Volume 59, Issue 1, Pages (January 2001)
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Presentation transcript:

Volume 70, Issue 11, Pages 1920-1928 (December 2006) Gender differences in renal nuclear receptors and aryl hydrocarbon receptor in 5/6 nephrectomized rats  H. Lu, X. Lei, C. Klaassen  Kidney International  Volume 70, Issue 11, Pages 1920-1928 (December 2006) DOI: 10.1038/sj.ki.5001880 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Renal enzyme activities of caspase-3 in 5/6 Nx rats. Kidney samples of male and female rats were collected 7 weeks after Nx. Renal caspase-3 activity was determined with a diagnostic kit. N=6–7. Error bars indicate s.e.m. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Renal mRNA expression of inflammation-related genes in 5/6 Nx rats. Kidney samples of male and female rats were collected 7 weeks after Nx. The mRNA expression of (a) IL-1β), (b) IL-6, (c) IL-10, (d) Fas, and (e) Fas ligand (FasL) in kidney total RNA was quantified with the bDNA signal amplification assay. N=6–7. Y axis represents renal mRNA of target genes expressed as RLU per 4 μg total RNA. Error bars indicate s.em. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group; #P<0.05 compared to corresponding male group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Blood and/or urine levels of E2, testosterone, and corticosteroid in 5/6 Nx rats. Blood and urine samples of male and female rats were collected 7 weeks after Nx. Blood and urine levels of steroid hormones were determined with radioimmunoassay kits. N=6–7. Error bars indicate s.e.m. (a) Plasma levels of corticosterone, (b) plasma levels of E2, (c) plasma levels of testosterone, and (d) urinary excretion of testosterone. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group; #P<0.05 compared to corresponding male group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Renal expression of steroid hormone receptors in 5/6 Nx rats. Kidney samples of male and female rats were collected 7 weeks after Nx. Renal mRNA expression of ERα, AR, and GR was quantified with the bDNA signal amplification assay. Renal protein expression of ERα was determined by Western blot. Y axis represents renal mRNA of target genes expressed as RLU per 4 μg total RNA. N=6–7. Error bars indicate s.e.m. (a) GR mRNA, (b) AR mRNA, (c) ERα mRNA, (d) ERα protein, (e) positive correlation of renal GR mRNA with GFR in Nx-males, and (f) positive correlation of renal ERα mRNA with GFR in Nx-males. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group; #P<0.05 compared to corresponding male group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Renal mRNA expression of PPARα and its downstream genes in 5/6 Nx rats. Kidney samples of male and female rats were collected 7 weeks after Nx. Renal mRNA expression of PPARα, AOX, Cyp4a1, and Cyp4a2/3 was quantified with the bDNA signal amplification assay. Y axis represents renal mRNA of target genes expressed as RLU per 4 μg total RNA. N=6–7. Error bars indicate s.e.m. (a) PPARα, (b) AOX, (c) negative correlation of renal PPARα mRNA with proteinuria in Nx-males and -females, (d) negative correlation of renal AOX mRNA with proteinuria in Nx-males and -females; (e) Cyp4a1; (f) Cyp4a2/3; (g) negative correlation of renal Cyp4a1 mRNA with renal caspase-3 activity in Nx-females; and (h) positive correlation of renal Cyp4a1 mRNA with blood levels of hemoglobin in Nx-males. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group; #P<0.05 compared to corresponding male group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 Renal expression of AhR and WT1 in 5/6 Nx rats. Kidney samples of male and female rats were collected 7 weeks after Nx. Renal mRNA expression of AhR and WT1 was quantified with the bDNA signal amplification assay. Renal protein expression of WT1 was determined by Western blot. Y axis represents renal mRNA of target genes expressed as RLU per 4 μg total RNA. N=6–7. Error bars indicate s.e.m. (a) AhR mRNA, (b) negative correlation of renal AhR mRNA with GFR in Nx-females, (c) WT1 mRNA, and (d) WT1 protein. SM, sham-operated male rats; NxM, 5/6 nephrectomized male rats; SF, sham-operated female rats; NxF, 5/6 nephrectomized female rats. *P<0.05 compared to corresponding sham-operated group; #P<0.05 compared to corresponding male group. Kidney International 2006 70, 1920-1928DOI: (10.1038/sj.ki.5001880) Copyright © 2006 International Society of Nephrology Terms and Conditions